BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for March 9, 2023

March 9, 2023
Med-tech firms raising money in public or private financings, including: Biomerica, Cardio Diagnostics.
Read More

Appointments and advancements for March 9, 2023

March 9, 2023
New hires and promotions in the med-tech industry, including: Alcami, Cardio Diagnostics, Prolira.
Read More

Regulatory actions for March 9, 2023

March 9, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antev, Biogen, Biomarin, Boehringer, Eli Lilly, Inhibikase, Mesoblast, Revive, Sage.
Read More

Other news to note for March 9, 2023

March 9, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpha Fusion, Biocytogen, Bridgene, Carisma, Gilead, J&J, Neoleukin, Selonterra, Sesen, Surface Oncology, Takeda, Tessa.
Read More

In the clinic for March 9, 2023

March 9, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications:  Achieve, Alterity, Biocorrx, Biothera, Cel-Sci, DBV, Fresh Tracks, JW, Molecure, Redx, Renovorx, Sernova, Sparrow, Vistagen.
Read More

Financings for March 9, 2023

March 9, 2023
Biopharmas raising money in public or private financings, including: Hemostemix, Iktos, Macrogenics, Nrx, Ring, Tiamat.
Read More

Appointments and advancements for March 9, 2023

March 9, 2023
New hires and promotions in the biopharma industry, including: Asklepios, Centogene, Evofem, Fulcrum, Homology, Lava, Nkgen, Pliant, Rome, Transgene.
Read More

Other news to note for March 8, 2023

March 8, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alimetrix, Aribio, Fujirebio, Microarrays, Miromatrix, Pharmajet, Sengine, Spectrum Solutions.
Read More

Financings for March 8, 2023

March 8, 2023
Med-tech firms raising money in public or private financings, including: Aiberry, Virax Biolabs.
Read More

Appointments and advancements for March 8, 2023

March 8, 2023
New hires and promotions in the med-tech industry, including: Accelerate Diagnostics, Aditxt, Aim Medical Robotics, Endoluxe, Heartbeam, Ivy Fertility, Maternova, Osteocentric, Swift Medical.
Read More
Previous 1 2 … 852 853 854 855 856 857 858 859 860 … 1808 1809 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing